1. Transitions in Care-Heart Failure
ACC Quality 2009
D2B-Sustain the Gain
Transitions in Care-Heart Failure
Patient Centered Care
Transformation
The IC3 Program

2. Goal Improving Continuous Cardiac Care
Help clinicians thrive in a performance-based reimbursement system through the systematic practice, timely reporting, and continuous improvement of quality
Goal
Improving
Continuous
Cardiac Care

3. Outpatient Performance Measures
CAD, Afib, HTN,
Heart failure,
Diabetes, Rehab
ACC/AHA
PCPI
PQRI
NQF
There is not much emphasis

4. Quality improvement Practice workflow redesign
Transactional quality and management
Incentives

5. Office-based quality improvement program that enables participants to select, based on practice characteristics, the most appropriate level of engagement
What is it?

6. The IC3 Program Community Education Data Incentives Research
Performance
Improvement
Data
Incentives
Research

7. Interactive communication.
Community Building
The IC3 national network of practices dedicated to high quality CV care.
Interactive communication.
Best practices.
There is not much emphasis

8. Education Educational programming. Clinical guideline updates.
Selection of EHR vendors.
Billing and coding.
There is not much emphasis

9. Data Collection Office-based registry.
Collect and use patient care data more effectively.
Coordinate care.
Benchmarking.
Demonstrate quality of care.

10. Performance Improvement
Practice assessment.
QI tools.
Decision support
(CardioPATH).
CardioPATH used IC3 data dictionary

11. Recognition and Rewards
Incentives.
Recognition.
ABIM MOC.
Payers.
Malpractice.
tipping points

12. Research New insights on care delivery. Impact of program.
Practice-Based Research Network.

13. Current ACC/AHA Performance Measures
CAD Performance Measures
BP Measurement
Symptom & Activity Assessment
Smoking Assessment
Anti-platelet Therapy
Lipid Profile
Use of Lipid Therapy
-blocker post-MI
ACE/ARB in EF & DM
Screening for Diabetes
CHF Performance Measures
LVEF Assessment
Weight Measurements
BP Measurements
Clinical Symptom Assessment
Activity Assessment
Signs of Volume Overload
Patient Education
-blocker in EF
ACE/ARB in EF
Warfarin for Afib
Initial Lab Tests

14. Current ACC/AHA Performance Measures
Afib Performance Measures
Thromboembolic Risk
Prior CVA/TIA
Age ≥75
Hypertension
Diabetes
Heart failure or EF
Warfarin use in High-risk pts
Monthly INR in pts on warfarin
Cardiac Rehabilitation PMs
Referral to a Rehab Program
Within 12 months of
ACS
PCI
CABG
Valve Surgery
Transplant
Stable Angina
Diabetes Performance Measures
Poor HbA1c (>9%)
LDL Control (<100)
BP Control (<140/80)

16. Quality Vision, near and far
2009: prepare practices to succeed 2010: make quality business case 2011: link learning, performance, $ 2012: Quality First Network